Swiss stocks - Factors to watch on November 1
01/11/2021 05:53
ZURICH/BERLIN, Nov 1 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Monday:
COMPANY STATEMENTS
* Novartis AG NOVN.S said the U.S. Food and Drug
Administration (FDA) had approved Scemblix (asciminib), for the
treatment of chronic myeloid leukaemia NOVN.S
* Obseva SA OBSN.S said Chief Financial Officer David
Renas will step down from his position for personal reasons,
effective January 5, 2022. OBSN.S
* Glarner Kantonalbank GLKBN.S said net operating profit
dropped by 5.4% to 21.0 million Swiss francs in the first nine
months of the year. GLKBN.S
ECONOMY
Swiss October manufacturing PMI due at 0830 GMT
SNB data on Swiss sight deposits due at 0900 GMT
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))